Dätwyler Holding AG (DAE.SW)
Altdorf, CH
Dätwyler Holding AG, established in 1915 and headquartered in Altdorf, Switzerland, operates as a subsidiary of Pema Holding AG. The company specializes in the global manufacturing and distribution of elastomer components for a variety of sectors, including healthcare, mobility, oil and gas, and food and beverage, with its reach extending across Europe, North America, South America, and Asia. Dätwyler is organized into two core divisions: Healthcare Solutions and Industrial Solutions. The Healthcare Solutions segment provides critical rubber components for medical applications such as prefilled syringes, injection pens, vial closures for injectable pharmaceuticals, blood collection systems, IV administration sets, disposable syringes, and diagnostic and medical devices. Meanwhile, the Industrial Solutions segment offers a diverse portfolio of products, including electromobility solutions, active assistance and safety systems, brake components, fuel and engine management systems, exhaust gas aftertreatment, and sealing components for upstream systems, power tools, and the water and process industries.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.49% | -1.73% | +1.02% | -5.60% | +1.41% | -4.92% | +34.41% | -29.82% | -47.91% | +6.02% | +737.82% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | 0 |
| Hold | 3 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Industrial - Specialties: +7.4%-0.7% Q4'25: -2.1% (vs Q4'23)
-
EPS growth Industrial - Specialties: +14.1%+159.6% ★ Q4'25: +23.5% (vs Q4'23)
-
FCF margin FCF growth · Industrial - Specialties: +45.6%+6.3% Q4'25: +11.5% (vs Q4'23)
-
EBIT margin Industrial - Specialties: +10.1%+10.2% ★ Q4'25: +10.2% (vs Q4'23)
-
ROIC Industrial - Specialties: +6.4%+10.7% ★ Q4'25: +21.9% (vs Q4'23)
-
Share dilution Industrial - Specialties: +0.0%+0.0% Q4'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Industrial - Specialties: -0.19×2.67× Q4'25: 1.38× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2001 actual |
Dec 2002 actual |
Dec 2003 actual |
Dec 2004 actual |
Dec 2005 actual |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 5 EPS Ana. |
Dec 2027 6 Rev. Ana. 5 EPS Ana. |
Dec 2028 5 Rev. Ana. 5 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.07B
est.
|
1.03B
est: 1.03B (-0.9%)
|
993.28M
est: 1.03B (-3.7%)
|
1.05B
est: 1.08B (-2.8%)
|
1.09B
est: 1.11B (-1.4%)
|
1.21B
est: 1.22B (-0.6%)
|
1.17B
est: 1.44B (-18.4%)
|
1.29B
est: 1.32B (-2.2%)
|
1.11B
est: 1.13B (-1.5%)
|
1.32B
est: 1.34B (-1.5%)
|
1.29B
est: 1.32B (-2.3%)
|
1.19B
est: 1.40B (-15.4%)
|
1.23B
est: 1.41B (-12.5%)
|
1.21B
est: 1.27B (-4.6%)
|
1.17B
est: 1.17B (+0.0%)
|
1.22B
est: 1.22B (-0.7%)
|
1.29B
est: 1.30B (-0.6%)
|
1.36B
est: 1.39B (-2.0%)
|
1.05B
est: 1.38B (-23.8%)
|
823.30M
est: 1.06B (-22.4%)
|
947.60M
est: 1.10B (-13.5%)
|
1.15B
est: 1.14B (+0.9%)
|
1.15B
est: 1.12B (+2.7%)
|
1.11B
est: 1.13B (-2.1%)
|
1.10B
est: 1.12B (-1.7%)
|
1.19B
1.16B – 1.21B
+5.8% YoY
|
1.27B
1.23B – 1.38B
+7.2% YoY
|
1.35B
1.32B – 1.37B
+6.1% YoY
|
1.36B
1.33B – 1.44B
+1.2% YoY
|
1.43B
1.39B – 1.51B
+4.9% YoY
|
| EBITDA |
116.11M
est.
|
522.38M
est: 97.12M (+437.9%)
|
474.73M
est: 52.24M (+808.8%)
|
493.18M
est: 92.50M (+433.2%)
|
507.54M
est: 97.95M (+418.2%)
|
151.70M
est: 120.08M (+26.3%)
|
161.00M
est: 133.63M (+20.5%)
|
192.00M
est: 257.25M (-25.4%)
|
126.90M
est: 150.68M (-15.8%)
|
180.30M
est: 139.58M (+29.2%)
|
168.30M
est: 157.79M (+6.7%)
|
160.70M
est: 172.78M (-7.0%)
|
182.20M
est: 188.21M (-3.2%)
|
181.20M
est: 159.25M (+13.8%)
|
174.00M
est: 163.91M (+6.2%)
|
161.90M
est: 166.87M (-3.0%)
|
213.80M
est: 115.72M (+84.8%)
|
235.10M
est: 219.79M (+7.0%)
|
201.90M
est: 204.92M (-1.5%)
|
193.00M
est: 5.91M (+3,166.2%)
|
225.50M
est: 6.19M (+3,542.4%)
|
224.30M
est: 6.56M (+3,317.6%)
|
187.20M
est: 201.17M (-6.9%)
|
144.10M
est: 203.25M (-29.1%)
|
188.70M
est: 200.90M (-6.1%)
|
212.63M
208.37M – 217.53M
+5.8% YoY
|
227.96M
219.99M – 247.20M
+7.2% YoY
|
241.82M
237.38M – 246.25M
+6.1% YoY
|
244.64M
237.86M – 258.02M
+1.2% YoY
|
256.62M
249.52M – 270.66M
+4.9% YoY
|
| EBIT |
59.28M
est.
|
417.97M
est: 45.33M (+822.0%)
|
410.63M
est: -4.49M (+9,253.5%)
|
412.17M
est: 35.37M (+1,065.4%)
|
63.10M
est: 40.97M (+54.0%)
|
73.90M
est: 71.41M (+3.5%)
|
115.60M
est: 91.52M (+26.3%)
|
139.90M
est: 102.39M (+36.6%)
|
74.20M
est: 114.50M (-35.2%)
|
114.10M
est: 94.87M (+20.3%)
|
119.60M
est: 126.06M (-5.1%)
|
104.70M
est: 126.93M (-17.5%)
|
131.20M
est: 104.98M (+25.0%)
|
133.60M
est: 118.19M (+13.0%)
|
125.60M
est: 124.47M (+0.9%)
|
98.10M
est: 132.42M (-25.9%)
|
162.50M
est: 154.97M (+4.9%)
|
166.90M
est: 174.08M (-4.1%)
|
133.50M
est: 172.36M (-22.5%)
|
129.90M
est: 102.12M (+27.2%)
|
159.50M
est: 106.99M (+49.1%)
|
149.20M
est: 113.42M (+31.5%)
|
106.30M
est: 123.43M (-13.9%)
|
63.00M
est: 124.79M (-49.5%)
|
112.30M
est: 123.26M (-8.9%)
|
130.46M
127.85M – 133.47M
+5.8% YoY
|
139.86M
134.98M – 151.67M
+7.2% YoY
|
148.37M
145.64M – 151.09M
+6.1% YoY
|
150.10M
145.94M – 158.31M
+1.2% YoY
|
157.45M
153.09M – 166.06M
+4.9% YoY
|
| Net Income |
45.28M
est.
|
-16.86M
est: 33.69M (-150.0%)
|
22.14M
est: -16.85M (+231.4%)
|
24.24M
est: 23.13M (+4.8%)
|
39.62M
est: 24.85M (+59.4%)
|
76.50M
est: 44.59M (+71.6%)
|
219.50M
est: 89.99M (+143.9%)
|
109.60M
est: 202.10M (-45.8%)
|
57.20M
est: 93.51M (-38.8%)
|
98.20M
est: 75.54M (+30.0%)
|
96.20M
est: 96.78M (-0.6%)
|
127.50M
est: 102.10M (+24.9%)
|
120.20M
est: 127.85M (-6.0%)
|
97.90M
est: 108.70M (-9.9%)
|
82.20M
est: 91.07M (-9.7%)
|
57.60M
est: 86.32M (-33.3%)
|
123.70M
est: 61.10M (+102.5%)
|
121.00M
est: 132.43M (-8.6%)
|
-86.60M
est: 120.13M (-172.1%)
|
-346.30M
est: -65.60M (-427.9%)
|
194.00M
est: -68.74M (+382.2%)
|
104.80M
est: 79.50M (+31.8%)
|
66.80M
est: 73.30M (-8.9%)
|
31.10M
est: 75.17M (-58.6%)
|
80.80M
est: 80.80M (+0.0%)
|
103.71M
95.03M – 106.76M
+28.4% YoY
|
125.82M
114.19M – 131.13M
+21.3% YoY
|
135.81M
131.98M – 157.07M
+7.9% YoY
|
143.48M
138.31M – 153.68M
+5.7% YoY
|
153.51M
147.98M – 164.42M
+7.0% YoY
|
| SGA |
306.93M
est.
|
310.65M
est: 293.18M (+6.0%)
|
304.96M
est: 309.74M (-1.5%)
|
313.42M
est: 319.15M (-1.8%)
|
315.62M
est: 321.77M (-1.9%)
|
331.50M
est: 347.23M (-4.5%)
|
309.30M
est: 327.01M (-5.4%)
|
340.10M
est: 284.78M (+19.4%)
|
326.60M
est: 290.18M (+12.5%)
|
333.00M
est: 388.73M (-14.3%)
|
329.70M
est: 346.53M (-4.9%)
|
174.30M
est: 158.56M (+9.9%)
|
170.60M
est: 136.67M (+24.8%)
|
184.30M
est: 154.28M (+19.5%)
|
151.00M
est: 171.44M (-11.9%)
|
164.70M
est: 158.57M (+3.9%)
|
158.70M
est: 174.69M (-9.2%)
|
166.40M
est: 169.90M (-2.1%)
|
128.60M
est: 99.38M (+29.4%)
|
79.60M
est: 100.07M (-20.5%)
|
80.80M
est: 104.85M (-22.9%)
|
91.30M
est: 111.15M (-17.9%)
|
99.50M
est: 97.39M (+2.2%)
|
100.20M
est: 98.39M (+1.8%)
|
102.10M
est: 97.26M (+5.0%)
|
102.93M
100.87M – 105.31M
+5.8% YoY
|
110.35M
106.50M – 119.67M
+7.2% YoY
|
117.06M
114.92M – 119.21M
+6.1% YoY
|
118.43M
115.15M – 124.91M
+1.2% YoY
|
124.23M
120.79M – 131.03M
+4.9% YoY
|
| EPS |
2.27
est.
|
-1.06
est: 1.43 (-174.2%)
|
1.41
est: 1.57 (-10.2%)
|
1.55
est: 1.54 (+0.4%)
|
2.55
est: 2.58 (-1.3%)
|
4.83
est: 4.34 (+11.3%)
|
13.85
est: 13.49 (+2.6%)
|
6.91
est: 6.62 (+4.4%)
|
4.01
est: 2.39 (+67.8%)
|
6.17
est: 6.17 (0.0%)
|
6.04
est: 5.37 (+12.4%)
|
7.99
est: 6.77 (+18.0%)
|
7.32
est: 6.67 (+9.8%)
|
6.23
est: 6.18 (+0.8%)
|
5.04
est: 5.27 (-4.4%)
|
3.47
est: 5.51 (-37.0%)
|
7.28
est: 7.25 (+0.5%)
|
7.12
est: 8.03 (-11.3%)
|
-5.09
est: 7.13 (-171.4%)
|
-20.37
est: 6.57 (-409.8%)
|
11.41
est: 9.33 (+22.3%)
|
6.16
est: 6.95 (-11.3%)
|
3.93
est: 4.31 (-8.8%)
|
1.83
est: 4.35 (-57.9%)
|
4.75
est: 4.82 (-1.5%)
|
5.91
5.59 – 6.28
+22.5% YoY
|
7.20
6.72 – 7.71
+21.9% YoY
|
8.32
7.76 – 9.24
+15.5% YoY
|
8.44
8.14 – 9.04
+1.5% YoY
|
9.03
8.70 – 9.67
+7.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-28 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-27 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-26 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-22 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-21 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-20 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-19 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis International Small Cap Value ETF AVDV | 0.12% | 22.27M | 0.36% |
| 2 | Xtrackers MSCI Europe Small Cap UCITS ETF 1C XXSC.L | 0.10% | 3.32M | 0.30% |
| 3 | iShares MSCI Europe Small-Cap ETF IEUS | 0.10% | 167.1K | 0.41% |
| 4 | iShares Core SPI(R) ETF (CH) CHSPI.SW | 0.06% | 4.39M | 0.10% |
| 5 | Avantis International Small Cap Equity ETF AVDS | 0.06% | 190.6K | 0.30% |
| 6 | Schwab International Small-Cap Equity ETF SCHC | 0.06% | 3.03M | 0.06% |
| 7 | Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Acc CEM.PA | 0.05% | 173.3K | 0.23% |
| 8 | Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF Dist X026.DE | 0.05% | 173.3K | 0.23% |
| 9 | Avantis Global Small Cap Value UCITS ETF AVGS.L | 0.05% | 494.4K | 0.39% |
| 10 | iShares Currency Hedged MSCI EAFE Small-Cap ETF HSCZ | 0.04% | 92.1K | 0.83% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Volker Cwielong | Chief Executive Officer & Member of Executive Board | 1M | male |
| Judith van Walsum | CFO, Head of the Group Function Finance & Shared Services and Member of Executive Board | 63.6K | — |
| Frank Schon | Chief Technology Officer, Head of Group Function Technology & Innovation & Member of Executive Board | — | — |
| Cindy Reiss-Clark | Chief Operating Officer, Head of Division Healthcare & Member of Executive Board | — | female |
| Katharina Immoor | Senior Vice President of Corporate Communications & Investor Relations | — | — |
| Michael Holler | COO, Head of Division Industrial & Member of Executive Board | — | male |
| Dirk Borghs | Chief Operating Officer, Head of Division Healthcare & Member of Executive Board | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DAE.SW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
